This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
09 Days
Publication after acceptance
06 Days
*Last 12 months
Viewed By 7190 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 6215 |
A decade of liver organoids: Advances in disease modeling |
Viewed By 4033 |
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy |
Viewed By 3396 |
MAFLD: How is it different from NAFLD? |
Viewed By 3040 |
Hepatorenal syndrome: Current concepts and future perspectives |
Cited By 117 |
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease |
Cited By 54 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 52 |
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? |
Cited By 46 |
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis |
Cited By 46 |
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis |